CBIO
Price
$15.06
Change
+$0.66 (+4.58%)
Updated
Aug 22 closing price
Capitalization
209.22M
GOVX
Price
$0.77
Change
+$0.02 (+2.67%)
Updated
Aug 22 closing price
Capitalization
19.01M
Interact to see
Advertisement

CBIO vs GOVX

Header iconCBIO vs GOVX Comparison
Open Charts CBIO vs GOVXBanner chart's image
Crescent Biopharma
Price$15.06
Change+$0.66 (+4.58%)
Volume$44.95K
Capitalization209.22M
GeoVax Labs
Price$0.77
Change+$0.02 (+2.67%)
Volume$872.6K
Capitalization19.01M
CBIO vs GOVX Comparison Chart in %
Loading...
CBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBIO vs. GOVX commentary
Aug 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBIO is a Buy and GOVX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2025
Stock price -- (CBIO: $15.06 vs. GOVX: $0.77)
Brand notoriety: CBIO and GOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBIO: 41% vs. GOVX: 41%
Market capitalization -- CBIO: $209.22M vs. GOVX: $19.01M
CBIO [@Biotechnology] is valued at $209.22M. GOVX’s [@Biotechnology] market capitalization is $19.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBIO’s FA Score shows that 2 FA rating(s) are green whileGOVX’s FA Score has 0 green FA rating(s).

  • CBIO’s FA Score: 2 green, 3 red.
  • GOVX’s FA Score: 0 green, 5 red.
According to our system of comparison, CBIO is a better buy in the long-term than GOVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBIO’s TA Score shows that 4 TA indicator(s) are bullish while GOVX’s TA Score has 4 bullish TA indicator(s).

  • CBIO’s TA Score: 4 bullish, 4 bearish.
  • GOVX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, GOVX is a better buy in the short-term than CBIO.

Price Growth

CBIO (@Biotechnology) experienced а +9.21% price change this week, while GOVX (@Biotechnology) price change was +0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CBIO($209M) has a higher market cap than GOVX($19M). CBIO YTD gains are higher at: 5948.193 vs. GOVX (-68.988). CBIO has more cash in the bank: 153M vs. GOVX (3.09M). GOVX has less debt than CBIO: GOVX (142K) vs CBIO (1.64M).
CBIOGOVXCBIO / GOVX
Capitalization209M19M1,100%
EBITDAN/A-24.71M-
Gain YTD5948.193-68.988-8,622%
P/E RatioN/AN/A-
RevenueN/A6.14M-
Total Cash153M3.09M4,945%
Total Debt1.64M142K1,158%
FUNDAMENTALS RATINGS
CBIO vs GOVX: Fundamental Ratings
CBIO
GOVX
OUTLOOK RATING
1..100
175
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3492
P/E GROWTH RATING
1..100
35100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBIO's Valuation (15) in the Biotechnology industry is somewhat better than the same rating for GOVX (51) in the null industry. This means that CBIO’s stock grew somewhat faster than GOVX’s over the last 12 months.

CBIO's Profit vs Risk Rating (30) in the Biotechnology industry is significantly better than the same rating for GOVX (100) in the null industry. This means that CBIO’s stock grew significantly faster than GOVX’s over the last 12 months.

CBIO's SMR Rating (100) in the Biotechnology industry is in the same range as GOVX (100) in the null industry. This means that CBIO’s stock grew similarly to GOVX’s over the last 12 months.

CBIO's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for GOVX (92) in the null industry. This means that CBIO’s stock grew somewhat faster than GOVX’s over the last 12 months.

CBIO's P/E Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for GOVX (100) in the null industry. This means that CBIO’s stock grew somewhat faster than GOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBIOGOVX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 18 days ago
87%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRNS90.434.40
+5.11%
Transcat
BYND2.450.06
+2.51%
Beyond Meat
VERX25.850.48
+1.89%
Vertex
FEMY0.57N/A
+0.62%
Femasys
TTWO229.031.16
+0.51%
Take-Two Interactive Software

CBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBIO has been loosely correlated with UTHR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CBIO jumps, then UTHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBIO
1D Price
Change %
CBIO100%
+4.58%
UTHR - CBIO
36%
Loosely correlated
+0.51%
NRXP - CBIO
27%
Poorly correlated
+4.35%
XLO - CBIO
26%
Poorly correlated
+4.94%
GOVX - CBIO
23%
Poorly correlated
+2.16%
TAOX - CBIO
23%
Poorly correlated
+18.60%
More

GOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOVX has been loosely correlated with TOVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GOVX jumps, then TOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOVX
1D Price
Change %
GOVX100%
+2.16%
TOVX - GOVX
54%
Loosely correlated
-0.23%
CING - GOVX
46%
Loosely correlated
+5.01%
VRAX - GOVX
40%
Loosely correlated
+3.21%
GRI - GOVX
37%
Loosely correlated
+0.72%
MAIA - GOVX
32%
Poorly correlated
+3.27%
More